À. La-hauteur, une mise à jour de la surveillance de la santé des jeunes du Canada. Prématurité, 2004.

R. Goldenberg, J. Culhane, J. Iams, and R. Romero, Epidemiology and causes of preterm birth, The Lancet, vol.371, issue.9606, pp.75-84, 2008.
DOI : 10.1016/S0140-6736(08)60074-4

B. Blondel and M. Kermarrec, Enquête national périnatale 2010 : les naissances en 2010 et leur évolution depuis, 2003.

E. Norwitz, J. Robinson, and J. Challis, The Control of Labor, New England Journal of Medicine, vol.341, issue.9, pp.660-666, 1999.
DOI : 10.1056/NEJM199908263410906

H. Leitich, M. Brunbauer, B. Bodner-adler, A. Kaider, C. Egarter et al., Antibiotic treatment of bacterial vaginosis in pregnancy: A meta-analysis, American Journal of Obstetrics and Gynecology, vol.188, issue.3, pp.752-760, 2003.
DOI : 10.1067/mob.2003.167

H. Johnson, K. Ghanem, J. Zenilman, and E. Erbelding, Sexually Transmitted Infections and Adverse Pregnancy Outcomes Among Women Attending Inner City Public Sexually Transmitted Diseases Clinics, Sexually Transmitted Diseases, vol.38, issue.3, pp.167-71, 2011.
DOI : 10.1097/OLQ.0b013e3181f2e85f

URL : http://pdfs.journals.lww.com/stdjournal/2011/03000/Sexually_Transmitted_Infections_and_Adverse.4.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1504502017267;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzd55NwvgNDyHIJ2wZu+16mr7F0q08EBmpB9gjv9rDuS2M=;hash|NhKMgodWo/aSnjGM2tn4uA==

G. Rours, L. Duijts, and H. Moll, Chlamydia trachomatis infection during pregnancy associated with preterm delivery: a population-based prospective cohort study, European Journal of Epidemiology, vol.122, issue.1, 2011.
DOI : 10.1016/j.ejogrb.2005.04.004

M. Cotch, J. Pastorek, and R. Nugent, Trichomonas vaginalis Associated With Low Birth Weight and Preterm Delivery, Sexually Transmitted Diseases, vol.24, issue.6, pp.353-60, 1997.
DOI : 10.1097/00007435-199707000-00008

B. Larsen, J. Hwang, and . Mycoplasma, , and Adverse Pregnancy Outcomes: A Fresh Look, Infectious Diseases in Obstetrics and Gynecology, vol.47, issue.3, 2010.
DOI : 10.1016/j.siny.2008.11.009

. Valkenburg-van-den, A. Berg, A. Sprij, F. Dekker, P. Dorr et al., and preterm delivery: A systematic review, Acta Obstetricia et Gynecologica Scandinavica, vol.88, issue.9, pp.958-67, 2009.
DOI : 10.1080/00016340903176800

H. Taeusch, R. Ballard, and C. Gleason, Avery's diseases of the newborn, 2005.

A. Czeizel, L. Rockenbauer, J. Olsen, and H. Sorensen, A teratological study of aminoglycoside antibiotic treatment during pregnancy, Scan J Infect Dis, vol.32, issue.3, pp.309-322, 2000.

G. Briggs, R. Freeman, and S. Yaffe, Drugs in pregnancy and lactation. A reference guide to fetal and neonatal risk, 2011.

A. Heinonen, O. Slone, D. Shapiro, and S. , Antimicrobial and antiparasitic agents Birth defects and drugs in pregnancy, pp.297-313, 1977.

A. Kirkwood, C. Harris, N. Timar, and G. Koren, Is Gentamicin Ototoxic to the Fetus?, Journal of Obstetrics and Gynaecology Canada, vol.29, issue.2, pp.140-145, 2007.
DOI : 10.1016/S1701-2163(16)32381-7

M. Berkovitch, I. Segal-socher, R. Greenberg, M. Bulkowshtein, J. Arnon et al., First trimester exposure to cefuroxime: a prospective cohort study, British Journal of Clinical Pharmacology, vol.163, issue.2, pp.161-166, 2000.
DOI : 10.1016/0002-9378(89)90186-5

C. Campbell, Quinolones : are they safe for children? Pharmacy Practice, pp.48-52, 2004.

B. Bar-oz, M. Moretti, R. Boskovic, O. Brien, L. Koren et al., The safety of quinolones???A meta-analysis of pregnancy outcomes, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.143, issue.2, pp.75-83, 2009.
DOI : 10.1016/j.ejogrb.2008.12.007

C. Schaeffer, E. Amoura-elefant, T. Vial, A. Ornoy, H. Garbis et al., Pregnancy outcome after prental quinolone exposure, Evaluation of a case registry of the European Network of Teratology Information Services (ENTIS)

R. Loebstein, A. Addis, E. Ho, R. Andreou, S. Sage et al., Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study, Antimicrob Agents Chemother, vol.42, issue.6, pp.1336-1345, 1998.

A. Czeizel, M. Rockenbauer, H. Sorensen, and J. Olsen, Augmentin treatment during pregnancy and the prevalence of congenital abnormalities, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.97, issue.2, pp.188-92, 2001.
DOI : 10.1016/S0301-2115(00)00545-5

M. Berkovitch, O. Diav-citrin, R. Greenberg, M. Cohen, M. Bulkowstein et al., First-trimester exposure to amoxycillin/clavulanic acid: a prospective, controlled study, British Journal of Clinical Pharmacology, vol.33, issue.3, pp.298-302, 2004.
DOI : 10.1016/0002-9378(92)91747-X

S. Kenyon, D. Taylor, and W. Tarnow-mordi, Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial, The Lancet, vol.357, issue.9261, pp.979-88, 2001.
DOI : 10.1016/S0140-6736(00)04233-1

A. Al-sabbagh, S. Moss, and N. Subhedar, Neonatal necrotising enterocolitis and perinatal exposure to co-amoxyclav, Archives of Disease in Childhood - Fetal and Neonatal Edition, vol.89, issue.2, p.187, 2004.
DOI : 10.1136/adc.2002.022731

URL : http://fn.bmj.com/content/fetalneonatal/89/2/F187.1.full.pdf

R. Ehsanipoor, J. Chung, C. Clock, J. Mcnulty, and D. Wing, A retrospective review of ampicillin-sulbactam and amoxicillin + clavulanate vs cefazolin/cephalexin and erythromycin in the setting of preterm premature rupture of membranes: maternal and neonatal outcomes, American Journal of Obstetrics and Gynecology, vol.198, issue.5, 2008.
DOI : 10.1016/j.ajog.2007.12.022

P. Aselton, H. Jick, A. Milunsky, J. Hunter, and . Stergachisa, First-trimester drug use and congenital disorders, Obstet Gynecol, vol.65, issue.4, pp.451-456, 1985.

B. Kallen, O. Olausson, P. Danielsson, and B. , Is erythromycin therapy teratogenic in humans?, Reproductive Toxicology, vol.20, issue.2, pp.209-223, 2005.
DOI : 10.1016/j.reprotox.2005.01.010

B. Mahon, M. Rosenman, and M. Kleiman, Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis, The Journal of Pediatrics, vol.139, issue.3, pp.380-384, 2001.
DOI : 10.1067/mpd.2001.117577

W. Cooper, W. Ray, and M. Griffin, Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis, Obstet Gynecol, vol.100, pp.101-107, 2002.

C. Louik, M. Werler, and A. Mitchell, Erythromycin use during pregnancy in relation to pyloric stenosis, American Journal of Obstetrics and Gynecology, vol.186, issue.2, pp.288-90, 2002.
DOI : 10.1067/mob.2002.119718

B. Bar-oz, O. Diav-citrin, and S. Shechtman, Pregnancy outcome after gestational exposure to the new macrolides: A prospective multi-center observational study, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.141, issue.1
DOI : 10.1016/j.ejogrb.2008.07.008

C. Drinkard, D. Shatin, and J. Clouse, Postmarketing surveillance of medications and pregnancy outcomes: Clarithromycin and birth malformations, Pharmacoepidemiology and Drug Safety, vol.44, issue.7
DOI : 10.1111/j.1365-3016.1996.tb00024.x

A. Einarson, E. Phillips, F. Mawji, D. 'alimonte, D. Schick et al., A Prospective Controlled Multicentre Study of Clarithromycin in Pregnancy, American Journal of Perinatology, vol.15, issue.09, pp.523-528, 1998.
DOI : 10.1055/s-2007-994053

M. Sarkar, C. Woodland, G. Koren, and A. Einarson, Pregnancy outcome following gestational exposure to azithromycin, BMC Pregnancy and Childbirth, vol.5, issue.5, p.18, 2006.
DOI : 10.1093/humupd/5.5.433

W. Cooper, S. Hernandez-diaz, and P. Arbogast, Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations, Paediatric and Perinatal Epidemiology, vol.19, issue.1
DOI : 10.1016/S0002-9378(87)80368-X

N. Van-den-broek, S. White, and M. Goodall, The APPLe Study: A Randomized, Community-Based, Placebo-Controlled Trial of Azithromycin for the Prevention of Preterm Birth, with Meta-Analysis, PLoS Medicine, vol.372, issue.12, p.1000191, 2009.
DOI : 10.1371/journal.pmed.1000191.s002

O. Diav-citrin, S. Shechtman, T. Gotteiner, J. Arnon, and A. Ornoy, Pregnancy outcome after gestational exposure to metronidazole: A prospective controlled cohort study, Teratology, vol.26, issue.5, pp.186-92, 2001.
DOI : 10.1016/S0027-5107(74)80049-7

P. Burtin, A. Taddio, O. Ariburnu, T. Einarson, and G. Koren, Safety of metronidazole in pregnancy: A meta-analysis, American Journal of Obstetrics and Gynecology, vol.172, issue.2, pp.525-534, 1995.
DOI : 10.1016/0002-9378(95)90567-7

T. Caro-paton, A. Carvajal, M. D. Diego, I. Martin-arias, L. et al., Is metronidazole teratogenic? A meta-analysis, British Journal of Clinical Pharmacology, vol.44, issue.2, pp.179-82, 1997.
DOI : 10.1046/j.1365-2125.1997.00660.x

Z. Kazy, E. Puho, and A. Czeizel, Teratogenic potential of vaginal metronidazole treatment during pregnancy, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.123, issue.2, pp.174-182, 2005.
DOI : 10.1016/j.ejogrb.2005.03.016

Z. Kazy, E. Puho, and A. Czeizel, The possible association between the combination of vaginal metronidazole and miconazole treatment and poly-syndactyly, Reproductive Toxicology, vol.20, issue.1, pp.89-94, 2005.
DOI : 10.1016/j.reprotox.2004.11.012

A. Morency and E. Bujold, The Effect of Second-Trimester Antibiotic Therapy on the Rate of Preterm Birth, Journal of Obstetrics and Gynaecology Canada, vol.29, issue.1, pp.35-44, 2007.
DOI : 10.1016/S1701-2163(16)32350-7

B. Kallen, O. Olausson, and P. , Maternal drug use in early pregnancy and infant cardiovascular defect, Reproductive Toxicology, vol.17, issue.3, pp.255-61, 2003.
DOI : 10.1016/S0890-6238(03)00012-1

J. Gait, Hemolytic Reactions to Nitrofurantoin in Patients with Glucose-6-Phosphate Dehydrogenase Deficiency: Theory and Practice, DICP, vol.25, issue.12, pp.1210-1213, 1990.
DOI : 10.1001/jama.1965.03090170135030

H. Bruel, V. Guillemant, C. Saladin-thiron, J. Chabrolle, A. Lahary et al., An??mie h??molytique chez un nouveau-n?? apr??s prise maternelle de nitrofuranto??ne en fin de grossesse, Archives de P??diatrie, vol.7, issue.7, pp.745-752, 2000.
DOI : 10.1016/S0929-693X(00)80155-4

A. Czeizel, M. Rockenbauer, H. Sorensen, and J. Olsen, Teratogenic evaluation of oxacillin, Scan J Infect Dis, vol.31, issue.3, pp.311-313, 1999.

A. Czeizel, M. Rockenbauer, H. Sorensen, and J. Olsen, The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study, Reproductive Toxicology, vol.15, issue.6, pp.637-683, 2001.
DOI : 10.1016/S0890-6238(01)00178-2

S. Hernandez-diaz, M. Werler, A. Walker, and A. Mitchell, Folic Acid Antagonists during Pregnancy and the Risk of Birth Defects, New England Journal of Medicine, vol.343, issue.22, pp.1608-1622, 2000.
DOI : 10.1056/NEJM200011303432204

S. Hernandez-diaz, M. Werler, A. Walker, and A. Mitchell, Neural Tube Defects in Relation to Use of Folic Acid Antagonists during Pregnancy, American Journal of Epidemiology, vol.153, issue.10, pp.961-969, 2001.
DOI : 10.1093/aje/153.10.961

5. C. Cotrimoxazole, Septembre, 2011.

P. Demers, D. Fraser, R. Goldbloom, J. Haworth, J. Larochelle et al., Effects of tetracyclines on skeletal growth and dentition. A report by the Nutrition Committee of the Canadian Paediatric Society, Can Med Assoc J, issue.17, pp.99849-54, 1968.

M. Reyes, E. Ostrea, A. Cabinian, C. Schmitt, and W. Rintelmann, Vancomycin during pregnancy: Does it cause hearing loss or nephrotoxicity in the infant?, American Journal of Obstetrics and Gynecology, vol.161, issue.4, pp.977-81, 1989.
DOI : 10.1016/0002-9378(89)90766-7

C. Egarter, H. Leitich, P. Husslein, A. Kaider, and M. Schemper, Adjunctive antibiotic treatment in preterm labor and neonatal morbidity: a meta-analysis, Obstetrics & Gynecology, vol.88, issue.2, pp.303-312, 1996.
DOI : 10.1016/0029-7844(96)00117-2

M. Luntamo, T. Kulmala, B. Mbewe, Y. Cheung, K. Maleta et al., Effect of Repeated Treatment of Pregnant Women with Sulfadoxine-Pyrimethamine and Azithromycin on Preterm Delivery in Malawi: A Randomized Controlled Trial, The American Journal of Tropical Medicine and Hygiene, vol.83, issue.6, pp.1212-1232, 2010.
DOI : 10.4269/ajtmh.2010.10-0264

B. Stoll, N. Hansen, and E. Bell, Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research Network, PEDIATRICS, vol.126, issue.3, pp.443-56, 2010.
DOI : 10.1542/peds.2009-2959

M. Bizzarro, L. Dembry, R. Baltimore, and P. Gallagher, Changing Patterns in Neonatal Escherichia coli Sepsis and Ampicillin Resistance in the Era of Intrapartum Antibiotic Prophylaxis, PEDIATRICS, vol.121, issue.4, pp.689-96, 2008.
DOI : 10.1542/peds.2007-2171

J. Bailit, K. Gregory, and U. Reddy, Maternal and neonatal outcomes by labor onset type and gestational age, American Journal of Obstetrics and Gynecology, vol.202, issue.3, pp.245-246, 2010.
DOI : 10.1016/j.ajog.2010.01.051

URL : http://europepmc.org/articles/pmc2888294?pdf=render

P. Kuhn, C. Dheu, and C. Bolender, Incidence and distribution of pathogens in early-onset neonatal sepsis in the era of antenatal antibiotics, Paediatric and Perinatal Epidemiology, vol.360, issue.2, pp.479-87, 2010.
DOI : 10.1111/j.1365-3016.2010.01132.x

J. Verani, L. Mcgee, and S. Schrag, Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010, MMWR Recomm Rep, vol.59, pp.1-36, 2010.

J. Silva, N. Antona, D. Six, C. Georges, S. Goulet et al., Infections néonatales à streptocoque B en France: données d'incidence de 1997 à 2006 et pratiques de prévention en maternité, BEH, pp.14-15110, 2008.

E. Arnaud, L. Spiesser-robelet, O. Bourdon, and O. Sibony, Antibiotiques et grossesse, Antibiotiques, vol.11, issue.2, pp.65-80, 2009.
DOI : 10.1016/j.antib.2008.11.004

S. Rao, M. Ahmed, and R. Hagan, One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates

K. Puopolo and E. Eichenwald, No Change in the Incidence of Ampicillin-Resistant, Neonatal, Early-Onset Sepsis Over 18 Years, PEDIATRICS, vol.125, issue.5, pp.1031-1039, 2010.
DOI : 10.1542/peds.2009-1573

C. Taketomo, J. Hodding, and D. Kraus, Pediatric dosage handbook with international trade names index

T. Heikkinen, K. Laine, P. Neuvonen, and U. Ekblad, The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin, BJOG: An International Journal of Obstetrics and Gynaecology, vol.25, issue.6, pp.770-775, 2000.
DOI : 10.1093/jac/25.suppl_A.109

P. Ramsey, M. Vaules, G. Vasdev, W. Andrews, and K. Ramin, Maternal and transplacental pharmacokinetics of azithromycin, American Journal of Obstetrics and Gynecology, vol.188, issue.3, pp.714-722, 2003.
DOI : 10.1067/mob.2003.141

C. Towers and G. Briggs, Antepartum use of antibiotics and early-onset neonatal sepsis: The next 4 years, American Journal of Obstetrics and Gynecology, vol.187, issue.2, pp.495-500, 2002.
DOI : 10.1067/mob.2002.124277

S. Kenyon, K. Pike, and D. Jones, Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial, The Lancet, vol.372, issue.9646, pp.1319-1346, 2008.
DOI : 10.1016/S0140-6736(08)61203-9

J. King and V. Flenady, Prophylactic antibiotics for inhibiting preterm labour with intact membranes, Cochrane Database Syst Rev, vol.18, issue.1, p.246, 2002.
DOI : 10.1056/NEJM199512283332603

J. Ranells, J. Carver, and R. Kirby, Infantile Hypertrophic Pyloric Stenosis: Epidemiology, Genetics, and Clinical Update, Advances in Pediatrics, vol.58, issue.1, pp.195-206, 2011.
DOI : 10.1016/j.yapd.2011.03.005

E. Baraldi and M. Filippone, Chronic Lung Disease after Premature Birth, New England Journal of Medicine, vol.357, issue.19, pp.1946-55, 2007.
DOI : 10.1056/NEJMra067279

L. Hartling, Y. Liang, and T. Lacaze-masmonteil, Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis, Archives of Disease in Childhood - Fetal and Neonatal Edition, vol.97, issue.1, 2011.
DOI : 10.1136/adc.2010.210187

S. Kotecha, R. Hodge, J. Schaber, R. Miralles, M. Silverman et al., Pulmonary Ureaplasma urealyticum Is Associated with the Development of Acute Lung Inflammation and Chronic Lung Disease in Preterm Infants, Pediatric Research, vol.58, issue.1, pp.61-69, 2004.
DOI : 10.1046/j.1365-2214.2002.00003.x

J. Tamaoki, The Effects of Macrolides on Inflammatory Cells, Chest, vol.125, issue.2, pp.41-50, 2004.
DOI : 10.1378/chest.125.2_suppl.41S

A. Matlow, C. Th-'ng, D. Kovach, P. Quinn, M. Dunn et al., Susceptibilities of neonatal respiratory isolates of Ureaplasma urealyticum to antimicrobial agents, Antimicrob Agents Chemother, vol.42, pp.1290-1292, 1998.

H. Ballard, M. Anstead, and L. Shook, Azithromycin in the extremely low birth weight infant for the prevention of Bronchopulmonary Dysplasia: a pilot study, Respiratory Research, vol.23, issue.3
DOI : 10.1038/sj.jp.7210873

H. Ballard, L. Shook, and P. Bernard, Use of azithromycin for the prevention of bronchopulmonary dysplasia in preterm infants: a randomized, double-blind, placebo controlled trial, Pediatric Pulmonology, vol.17, issue.5 pt2, pp.111-119, 2011.
DOI : 10.1097/00006454-199807000-00008

J. Neu and W. Walker, Necrotizing Enterocolitis, New England Journal of Medicine, vol.364, issue.3, pp.255-64, 2011.
DOI : 10.1056/NEJMra1005408

W. Bradshaw, Necrotizing Enterocolitis, The Journal of Perinatal & Neonatal Nursing, vol.23, issue.1, pp.87-94, 2009.
DOI : 10.1097/JPN.0b013e318196fefb

A. Okogbule-wonodi, G. Gross, and C. Sun, Necrotizing Enterocolitis Is Associated With Ureaplasma Colonization in Preterm Infants, Pediatric Research, vol.67, issue.5 Part 1, pp.442-449, 2011.
DOI : 10.1016/j.diagmicrobio.2009.12.023

J. Milot and . L-'origine-de-la-rétinopathie-de-la-prématurité, Paediatr Child Health 2007 septembre, pp.553-556